A. Panossian, N. Fleury-Brégeot, A. Marinetti
FULL PAPER
chromatography with heptane/ethyl acetate (2:8) as the eluent (Rf
4.48 (m, 2 H, NCH2), 5.79 (1 H, NCHPh), 6.73 (d, 3JH,P = 11.9 Hz,
1
3
3
= 0.3). Pale-yellow oil. 31P NMR (CDCl3): δ = 10 ppm. H NMR
1 H, C=CH), 7.23 (d, J = 8.0 Hz, 2 H, Ts), 7.48 (d, J = 8.5 Hz,
3
3
(300 MHz, CDCl3): δ = 0.95 (t, J = 7.0 Hz, 3 H, Me), 1.17 (t, J
2 H), 7.52 (d, 3J = 8.0 Hz, 2 H, Ts), 8.14 (d, 3J = 8.5 Hz, 2 H) ppm.
= 7.0 Hz, 3 H, Me), 2.38 (s, 3 H, Me), 3.5–3.6 (m, 1 H, OCH2), 13C NMR (CDCl3): δ = 21.3 (Me), 21.5 (Me), 32.3 (d, JC,P
=
=
3
3
2
3.7–3.9 (m, 3 H, OCH2), 3.78 (s, 3 H, OMe), 4.34 (m, 1 H, NCH2),
6.4 Hz, CMe2), 56.1 (d, JC,P = 16.9 Hz, NCH2), 70.0 (d, JC,P
4.48 (m, 1 H, NCH2), 5.62 (1 H, NCHPh), 6.62 (d, 3JH,P = 12.0 Hz, 20.5 Hz, NCHPh), 75.9 (d, 2JC,P = 108.8 Hz, OCH2), 75.9 (d, 2JC,P
1 H, C=CH), 6.78 (d, 3J = 8.7 Hz, 2 H), 7.13 (d, 3J = 8.7 Hz, 2
H), 7.17 (d, 3J = 8.2 Hz, 2 H, Ts), 7.46 (d, 3J = 8.2 Hz, 2 H,
Ts) ppm. 13C NMR (CDCl3): δ = 15.8 (d, 3JC,P = 7.0 Hz, Me), 16.2
= 109.1 Hz, OCH2), 123.6, 127.2, 128.8, 129.9, 131.6 (d, JC,P
=
1
2
196 Hz, =C,P), 134.5 (C), 141.6 (d, JC,P = 11.1 Hz, CH=C), 144.2
(C-Me), 146.0 (C), 147.8 (C) ppm. HRMS: calcd. for C22H26N2Na-
O7PS 515.1018; found 515.1003.
3
3
(d, JC,P = 6.6 Hz, Me), 21.5 (Me), 55.3 (OMe), 55.6 (d, JC,P
=
=
2
2
17.4 Hz, NCH2), 61.9 (d, JC,P = 6 Hz, OCH2), 62.0 (d, JC,P
[4+2] Cyclization Reactions Between Diethyl (Buta-2,3-dien-2-yl)-
phosphonate (1c) and Imines. Typical Procedure: Diethyl (buta-2,3-
dien-2-yl)phosphonate (1c) (0.3 mmol, 60 mg) and the imine
(0.3 mmol) were dissolved in anhydrous toluene (1 mL) under Ar
in an oven-dried 5 mL vial. A 1 solution of the phosphane cata-
lyst in toluene (30 µL, 0.03 mmol) was then added. The vial was
capped and the reaction mixture heated at 120 °C for 24 h. The
solvent was removed and the final product was purified by column
chromatography.
2
6 Hz, OCH2), 70.6 (d, JC,P = 19.8 Hz, NCHPh), 113.6, 127.1,
128.9, 129.4, 131.3 (C), 134.0 (d, 1JC,P = 196 Hz, =C,P), 135.5 (C),
2
139.8 (d, JC,P = 11.8 Hz, CH=C), 143.3 (C-Me), 159.5 (C-
OMe) ppm. HRMS: calcd. for C22H28NNaO6PS 488.1273; found
488.1272. HPLC: Chiracel AD, heptanes/iPrOH (80:20), 1 mL/min,
15.0 (major) and 17.2 min.
Diethyl [2-(o-Tolyl)-1-tosyl-2,5-dihydro-1H-pyrrol-3-yl]phosphonate
(3d): Purification was performed by silica gel column chromatog-
raphy with heptane/ethyl acetate (2:8) as the eluent (Rf = 0.3). Pale-
yellow solid, m.p. 90 °C. 31P NMR (CDCl3): δ = 10 ppm. 1H NMR
Diethyl
(6-Phenyl-1-tosyl-1,2,5,6-tetrahydropyridin-3-yl)phos-
phonate (6a): Column chromatography on silica gel with heptane/
ethyl acetate (2:8) as the eluent afforded 94 mg (70% yield) of 6a
(Rf = 0.3) as a colorless solid, m.p. 81 °C. 31P NMR (CDCl3): δ =
3
3
(300 MHz, CDCl3): δ = 0.89 (t, J = 7.0 Hz, 3 H, Me), 1.18 (t, J
= 7.1 Hz, 3 H, Me), 2.38 (s, 3 H, Me), 2.49 (s, 3 H, Me), 3.4 (m, 1
2
H, OCH2), 3.7–3.9 (m, 3 H, OCH2), 4.42 (m, JAB = 16 Hz, 1 H,
1
3
15.6 ppm. H NMR (CDCl3): δ = 1.11 (t, J = 7.2 Hz, 3 H, Me),
2
NCH2), 4.54 (m, JAB = 16 Hz, 1 H, NCH2), 6.02 (1 H, NCHPh),
3
1.31 (t, J = 7.0 Hz, 3 H, Me), 2.43 (4 H, Me, CH2), 2.63 (d, J =
18 Hz, 1 H, CH2), 3.34 (d, JAB = 19 Hz, 1 H, NCH2), 3.8 (m, 1
3
6.69 (d, JH,P = 11.6 Hz, 1 H, C=CH), 6.9–7.1 (4 H, CHTol), 7.14
2
3
3
(d, J = 8.4 Hz, 2 H, Ts), 7.40 (d, J = 8.4 Hz, 2 H, Ts) ppm. 13C
H, OCH2), 3.9 (m, 1 H, OCH2), 4.0 (m, 2 H, OCH2), 4.29 (dd,
3
3
NMR (CDCl3): δ = 15.7 (d, JC,P = 6.9 Hz, Me), 16.1 (d, JC,P
=
2JAB = 19, J = 5.2 Hz, 1 H, NCH2), 5.34 (d, 3J = 6.4 Hz, 1 H,
6.3 Hz, Me), 19.0 (Me), 21.4 (Me), 55.8 (d, 3JC,P = 22.9 Hz, NCH2),
3
NCHPh), 6.81 (d, JH,P = 21 Hz, 1 H, C=CH), 7.2–7.3 (7 H), 7.70
2
2
61.8 (d, JC,P = 5 Hz, OCH2), 61.9 (d, JC,P = 5 Hz, OCH2), 67.1
(d, 2JC,P = 20 Hz, NCHPh), 126.0, 127.0, 127.8, 128.0, 129.4, 130.5,
134.0 (d, JC,P = 199 Hz, =C,P), 135.7 (C), 136.2 (C), 137.3 (C),
(d, 3J = 8.0 Hz, 2 H, Ts) ppm. 13C NMR (CDCl3): δ = 16.1 (d,
3
3JC,P = 6.1 Hz, Me), 16.3 (d, JC,P = 6.5 Hz, Me), 21.5 (Me), 26.5
1
3
2
(d, JC,P = 15.5 Hz, CH2), 39.8 (d, JC,P = 17.4 Hz, NCH2), 52.0
2
140.0 (d, JC,P = 12.2 Hz, CH=C), 143.2 (C-Me) ppm. HRMS:
2
2
(NCHPh), 61.8 (d, JC,P = 5.1 Hz, OCH2), 61.9 (d, JC,P = 5.4 Hz,
OCH2), 125.9 (d, 1JC,P = 184 Hz, =C,P), 127.0, 127.1, 127.2, 127.9,
128.5, 129.7, 137.5 (C), 137.9 (C), 139.8 (d, 2JC,P = 7.9 Hz, CH=C),
143.5 (C-Me) ppm. HRMS: calcd. for C22H28NNaO5PS 472.1324;
found 472.1313.
calcd. for C22H28NNaO5PS 472.1324; found 472.1313.
5,5-Dimethyl-2-oxo-2-(2-phenyl-1-tosyl-2,5-dihydro-1H-pyrrol-3-yl)-
1,3,2-dioxaphosphinane (5a): Purification was performed by silica
gel column chromatography with heptane/ethyl acetate (3:7) as the
eluent (Rf = 0.2). Colorless solid, m.p. 186 °C. 31P NMR (CDCl3):
Diethyl [6-(p-Methoxyphenyl)-1-tosyl-1,2,5,6-tetrahydropyridin-3-
yl]phosphonate (6c): Purification by column chromatography on sil-
ica gel with heptane/ethyl acetate (2:8) as the eluent afforded
107 mg (74% yield) of 6c (Rf = 0.3) as a colorless solid, m.p. 92 °C.
1
δ = 5 ppm. H NMR (CDCl3): δ = 0.70 (s, 3 H, Me), 0.98 (s, 3 H,
Me), 2.37 (s, 3 H, Me), 3.40 (t, JH,H = JH,P = 11 Hz, 1 H, OCH2),
3.43 (t, JH,H = JH,P = 11 Hz, 1 H, OCH2), 3.76 (t, JH,H = JH,P
=
1
31P NMR (CDCl3): δ = 15.7 ppm. H NMR (CDCl3): δ = 1.15 (t,
11 Hz, 1 H, OCH2), 3.92 (t, JH,H = JH,P = 11 Hz, 1 H, OCH2),
2
2
3
3J = 7.0 Hz, 3 H, Me), 1.33 (t, J = 7.0 Hz, 3 H, Me), 2.43 (4 H,
4.39 (m, JAB = 16.5 Hz, 1 H, NCH2), 4.89 (m, JAB = 16.5 Hz, 1
3
2
H, NCH2), 5.75 (1 H, NCHPh), 6.73 (d, JH,P = 12.5 Hz, 1 H,
Me, CH2), 2.58 (br. d, 1 H, CH2), 3.34 (d, JAB = 19 Hz, 1 H,
3
C=CH), 7.16 (d, J = 8.0 Hz, 2 H, Ts), 7.3–7.4 (5 H, Ph), 7.43 (d,
NCH2), 3.79 (s, 3 H, OMe), 3.8 (m, 1 H, OCH2), 3.9 (m, 1 H,
OCH2), 4.0 (m, 2 H, OCH2), 4.28 (dd, 2JAB = 19, J = 6.0 Hz, 1 H,
NCH2), 5.30 (d, 3J = 7.0 Hz, 1 H, NCH), 6.8 (3 H, C=CH,
3J = 8.0 Hz, 2 H, Ts) ppm. 13C NMR (CDCl3): δ = 21.1 (Me), 21.5
3
3
(Me), 21.6 (Me), 32.2 (d, JC,P = 6.7 Hz, CMe2), 55.7 (d, JC,P
17.2 Hz, NCH2), 70.9 (d, JC,P = 20.6 Hz, NCHPh), 75.8 (d, JC,P
=
2
2
3
3
CHo-Me), 7.20 (d, J = 8.5 Hz, 2 H, Ar), 7.27 (d, J = 8.0 Hz, 2 H,
2
Ar), 7.71 (d, J = 8.5 Hz, 2 H, Ts) ppm. 13C NMR (CDCl3): δ =
16.1 (d, JC,P = 5.5 Hz, Me), 16.3 (d, JC,P = 5.9 Hz, Me), 21.5
(Me), 26.8 (d, JC,P = 15.3 Hz, CH2), 39.7 (d, JC,P = 17.3 Hz,
NCH2), 51.6 (NCH), 55.3 (OMe), 61.8 (d, JC,P = 4.8 Hz, OCH2),
3
= 85.0 Hz, OCH2), 75.9 (d, JC,P = 85.1 Hz, OCH2), 127.1, 128.1,
128.4, 129.6, 132.6 (d, 1JC,P = 194 Hz, =C,P), 135.2 (C), 138.7 (C),
3
3
2
3
2
141.4 (d, JC,P = 11.3 Hz, CH=C), 143.5 (C-Me) ppm. HRMS:
2
calcd. for C22H26NNaO5PS 470.1167; found 470.1187. HPLC: Chi-
ralpak AD column, heptane/2-propanol (80:20), 1 mL/min, 18.9
(major) and 24.9 min.
2
1
61.9 (d, JC,P = 5.2 Hz, OCH2), 113.8 (CHo-MeO), 126.0 (d, JC,P
=
184 Hz, =C,P), 127.0, 128.5, 129.7, 129.9 (C), 137.6 (C), 139.9 (d,
2JC,P = 7.7 Hz, CH=C), 143.5 (C-Me), 159.2 (C-OMe) ppm.
HRMS: calcd. for C23H30NNaO6PS 502.1429; found 502.1397.
5,5-Dimethyl-2-oxo-2-[2-(p-nitrophenyl)-1-tosyl-2,5-dihydro-1H-pyr-
rol-3-yl]-1,3,2-dioxaphosphinane (5b): Purification was performed
by silica gel column chromatography with heptane/ethyl acetate
(3:7) as the eluent (Rf = 0.2). Pale-yellow oil. 31P NMR (CDCl3):
Diethyl [6-(o-Tolyl)-1-tosyl-1,2,5,6-tetrahydropyridin-3-yl]phosphon-
ate (6d): Purification by column chromatography on silica gel with
heptane/ethyl acetate (2:8) as the eluent afforded 103 mg (75%
yield) of 6d (Rf = 0.25) as a colorless oil. 31P NMR (CDCl3): δ =
1
δ = 4 ppm. H NMR (CDCl3): δ = 0.82 (s, 3 H, Me), 0.97 (s, 3 H,
Me), 2.40 (s, 3 H, Me), 3.48 (t, JH,H = JH,P = 11 Hz, 1 H, OCH2),
1
3
3.63 (t, JH,H = JH,P = 11 Hz, 1 H, OCH2), 3.86 (t, JH,H = JH,P
=
15.7 ppm. H NMR (CDCl3): δ = 1.13 (t, J = 7.0 Hz, 3 H, Me),
11 Hz, 1 H, OCH2), 4.06 (t, JH,H = JH,P = 11 Hz, 1 H, OCH2), 1.31 (t, 3J = 7.0 Hz, 3 H, Me), 2.33 (s, 3 H, Me), 2.45 (s, 3 H, Me),
3830
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 3826–3833